Find clinical trials for Diabetes in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Seattle, WA, USA:
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Seattle, Washington, United States and 17 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Tacoma, Washington, United States and 9 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Seattle, Washington, United States and 24 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Bellevue, Washington, United States of America and 40 other locations
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....
Phase 3
Seattle, Washington, United States and 32 other locations
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...
Phase 1, Phase 2
Seattle, Washington, United States and 28 other locations
This study will examine the safety of three times weekly SC injections of OPT101 at each of three dose levels over two weeks as well as one year of t...
Phase 2
Renton, Washington, United States of America
BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setti...
Phase 4
Seattle, Washington, United States
The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes....
Seattle, Washington, United States and 30 other locations
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
Seattle, Washington, United States and 29 other locations
Clinical trials
Research sites
Resources
Legal